X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/06/2841336/0/en/Zenas-BioPharma-Appoints-Patricia-Allen-to-its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2023/12/04/2789945/0/en/Zenas-BioPharma-Strengthens-Executive-Leadership-with-Appointment-of-Jennifer-Fox-as-Chief-Business-Officer-and-Chief-Financial-Officer-and-Tanya-Fischer-M-D-PhD-as-Head-of-R-D-and.html
https://zenasbio.com/news/zenas-biopharma-announces-strategic-license-and-collaboration-agreement-with-bristol-myers-squibb/
https://www.globenewswire.com/news-release/2023/08/01/2715830/0/en/Zenas-BioPharma-Announces-Publication-of-Phase-2-Study-of-Obexelimab-an-Investigational-Treatment-for-IgG4-Related-Disease-IgG4-RD-in-The-Lancet-Rheumatology.html
https://www.globenewswire.com/news-release/2023/01/11/2586899/0/en/Zenas-BioPharma-Announces-First-Patient-Dosed-in-Phase-3-Clinical-Study-of-Obexelimab-for-the-Treatment-of-Immunoglobulin-G4-Related-Disease-IgG4-RD.html
https://www.fiercebiotech.com/biotech/zenas-zips-118m-series-b-launch-phase-3-rare-autoimmune-disease-candidate
https://www.globenewswire.com/news-release/2022/11/07/2550164/0/en/Zenas-BioPharma-Secures-118-Million-to-Advance-Its-Broad-Pipeline-of-Autoimmune-Disease-Therapeutics.html
https://www.globenewswire.com/news-release/2022/07/31/2489072/0/en/Zenas-BioPharma-Obtains-IND-Approval-in-China-for-Phase-1-2-Study-of-ZB001-for-the-Treatment-of-Thyroid-Eye-Disease.html
https://www.globenewswire.com/news-release/2022/07/31/2489072/0/en/Zenas-BioPharma-Obtains-IND-Approval-in-China-for-Phase-1-2-Study-of-ZB001-for-the-Treatment-of-Thyroid-Eye-Disease.html
https://www.globenewswire.com/news-release/2022/05/15/2443390/0/en/Zenas-BioPharma-Submits-Investigational-New-Drug-Application-in-China-for-ZB001-for-the-Treatment-of-Thyroid-Eye-Disease.html
Market Place
Share 
